Overview of HFpEF Disease State and Physiological Rationale for Atrial Shunting
We Recommend
Disclosures
Within the last 24 months, I have financial relationship(s) or affiliation(s) with a manufacturer, marketer, reseller, or distributor of a healthcare product or service involved in the management of patients with any cardiovascular disease to include devices, drugs, and digital health care products listed below:
- Consultant Fee/Honoraria/Speaker's Bureau (Personal) - Abbott Vascular; AstraZenca; Edwards Lifesciences; Boston Scientific Corporation; St. Jude Medical; Boehringer Ingelheim; Vwave; CVRx; Impulse dynamics; Merck/Schering Plough
- Grant Support/Research Contract (Institutional) - AstraZenca